Cargando…

Pre-pregnancy check-up of maternal vascular status and associated phenotype is crucial for the health of mother and offspring

ABSTRACT: Cardiovascular disease remains the leading cause of disease burden globally with far-reaching consequences including enormous socio-economic burden to healthcare and society at large. Cardiovascular health is decisive for reproductive function, healthy pregnancy and postpartum. During preg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evsevieva, Maria, Sergeeva, Oksana, Mazurakova, Alena, Koklesova, Lenka, Prokhorenko-Kolomoytseva, Irina, Shchetinin, Evgenij, Birkenbihl, Colin, Costigliola, Vincenzo, Kubatka, Peter, Golubnitschaja, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437153/ https://www.ncbi.nlm.nih.gov/pubmed/36061831 http://dx.doi.org/10.1007/s13167-022-00294-1

Ejemplares similares

Mitochondrial health quality control: measurements and interpretation in the framework of predictive, preventive, and personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2022)

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person
por: Koklesova, Lenka, et al.
Publicado: (2021)

Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine
por: Kapinova, Andrea, et al.
Publicado: (2023)

Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
por: Zhai, Kevin, et al.
Publicado: (2021)

Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper
por: Golubnitschaja, Olga, et al.
Publicado: (2022)

Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
por: Liskova, Alena, et al.
Publicado: (2021)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management
por: Liskova, Alena, et al.
Publicado: (2020)

Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management—Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine
por: Koklesova, Lenka, et al.
Publicado: (2023)

Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
por: Crigna, Adriana Torres, et al.
Publicado: (2020)

Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation
por: Kropp, Martina, et al.
Publicado: (2023)

Antithrombotic and antiplatelet effects of plant-derived compounds: a great utility potential for primary, secondary, and tertiary care in the framework of 3P medicine
por: Kubatka, Peter, et al.
Publicado: (2022)

Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
por: Kubatka, Peter, et al.
Publicado: (2021)

Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Promoting predictive, preventive and personalised medicine in global scale: the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Time for new guidelines in personalised healthcare: PPPM related legislation
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Dental health: EPMA recommendations for innovative strategies
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements
por: Golubnitschaja, Olga, et al.
Publicado: (2015)

Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses
por: Hassan, Sherif T. S., et al.
Publicado: (2022)

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
por: Samuel, Samson Mathews, et al.
Publicado: (2020)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Flavonoids’ Dual Benefits in Gastrointestinal Cancer and Diabetes: A Potential Treatment on the Horizon?
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Prostate cancer treatment costs increase more rapidly than for any other cancer—how to reverse the trend?
por: Ellinger, J., et al.
Publicado: (2022)

Carotenoids in Cancer Apoptosis—The Road from Bench to Bedside and Back
por: Koklesova, Lenka, et al.
Publicado: (2020)

Carotenoids in Cancer Metastasis—Status Quo and Outlook
por: Koklesova, Lenka, et al.
Publicado: (2020)

The central role of laboratory medicine as the integrating element in healthcare services
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks
por: Liskova, Alena, et al.
Publicado: (2021)

Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine
por: Koklesova, Lenka, et al.
Publicado: (2021)

Promoting predictive, preventive and personalised medicine: European event of global importance
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Vision of the first EPMA center for predictive, preventive and personalized medicine in Europe
por: Kapalla, Marko, et al.
Publicado: (2014)

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020
por: Golubnitschaja, Olga, et al.
Publicado: (2020)

Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021
por: Golubnitschaja, Olga, et al.
Publicado: (2021)

Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare
por: Zubor, Pavol, et al.
Publicado: (2020)

Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights
por: Šudomová, Miroslava, et al.
Publicado: (2022)

Heredity and vascular endothelium: focus on young age
por: Evsevieva, Maria E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m2frithhjc2bbg2nnhrr15b9cg